David A. Brenner

Active 1980–2025

280
Papers
71,658
Citations
149
h-index
279
i10-index

Citations

Citations per year for David A. Brenner1968: 1 citations1978: 1 citations1981: 2 citations1982: 1 citations1985: 1 citations1986: 3 citations1987: 2 citations1988: 7 citations1989: 23 citations1990: 64 citations1991: 57 citations1992: 42 citations1993: 71 citations1994: 71 citations1995: 101 citations1996: 101 citations1997: 113 citations1998: 149 citations1999: 222 citations2000: 288 citations2001: 329 citations2002: 325 citations2003: 388 citations2004: 369 citations2005: 404 citations2006: 417 citations2007: 452 citations2008: 522 citations2009: 545 citations2010: 507 citations2011: 590 citations2012: 707 citations2013: 743 citations2014: 864 citations2015: 806 citations2016: 919 citations2017: 859 citations2018: 914 citations2019: 2,261 citations2020: 2,823 citations2021: 2,786 citations2022: 2,329 citations2023: 2,001 citations2024: 2,786 citations2025: 1,499 citations2026: 40 citations1969–1977: no citations, so these years are not shown1979–1980: no citations, so these years are not shown1983–1984: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 7,724 citing papers, 27.4% of this breakdownChina: 5,184 citing papers, 18.4% of this breakdownGermany: 1,485 citing papers, 5.2% of this breakdownUnited Kingdom: 1,319 citing papers, 4.7% of this breakdownItaly: 1,074 citing papers, 3.8% of this breakdownJapan: 1,051 citing papers, 3.7% of this breakdownFrance: 786 citing papers, 2.8% of this breakdownSpain: 728 citing papers, 2.6% of this breakdownSouth Korea: 696 citing papers, 2.5% of this breakdownCanada: 671 citing papers, 2.4% of this breakdownAustralia: 557 citing papers, 2% of this breakdownNetherlands: 482 citing papers, 1.7% of this breakdown
0%27.4%Other 22.8%

Fields

  • Medicine58.2%
  • Biochemistry, Genetics and Molecular Biology27.7%
  • Immunology and Microbiology4.9%
  • Neuroscience3.4%
  • Pharmacology, Toxicology and Pharmaceutics1.6%
  • Nursing1%
  • Other3.2%

Topics

  • Liver Disease Diagnosis and Treatment11%
  • Liver physiology and pathology5%
  • Gut microbiota and health3.6%
  • Liver Disease and Transplantation2.5%
  • Alcohol Consumption and Health Effects2.1%
  • Diet, Metabolism, and Disease1.9%
  • Other73.9%

Coauthors

All papers

Open in search
  1. Molecular and cellular mechanisms of liver fibrosis and its regression

    Authors: , - Nature Reviews Gastroenterology & Hepatology 2020 cited by 1,918

  2. The gut–liver axis and the intersection with the microbiome

    Authors: , , , , , , - Nature Reviews Gastroenterology & Hepatology 2018 cited by 1,424

  3. Gut Microbiome-Based Metagenomic Signature for Non-invasive Detection of Advanced Fibrosis in Human Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , , , , , , - Cell Metabolism 2017 cited by 1,097

  4. Liver inflammation and fibrosis

    Authors: , - Journal of Clinical Investigation 2017 cited by 1,275

  5. Wastewater sequencing reveals early cryptic SARS-CoV-2 variant transmission

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Rodolfo A. Salido, Phoebe Seaver, Elizabeth W. Smoot, Daniel McDonald, Robert M. Neuhard, Angela L. Scioscia, Alysson M. Satterlund, Elizabeth H. Simmons, Dismas B. Abelman, David A. Brenner, Judith C. Bruner, Anne F. Buckley, M. Ellison, Jeffrey Gattas, Steven L. Gonias, Matt Hale, Faith Hawkins, Lydia Ikeda, Hemlata Jhaveri, Ted W. Johnson, Vince Kellen, Brendan Kremer, Gary Matthews, Ronald W. McLawhon, Pierre Ouillet, Daniel Park, Allorah Pradenas, Sharon L. Reed, Lindsay Riggs, Alison Sanders, Bradley Sollenberger, Angela Song, Benjamin L. White, Terri Winbush, Christine M. Aceves, Catelyn Anderson, Karthik Gangavarapu, Emory Hufbauer, Ezra Kurzban, Justin Lee, Nathaniel L. Matteson, Edyth Parker, Sarah A. Perkins, Karthik Ramesh, Refugio Robles‐Sikisaka, Madison Schwab, Emily Spencer, Shirlee Wohl, Laura Nicholson, Ian McHardy, David Dimmock, Charlotte A. Hobbs, Omid Bakhtar, Aaron Harding, Art Mendoza, Alexandre Bolze, David G. Becker, Elizabeth T. Cirulli, Magnus Isaksson, Kelly M. Schiabor Barrett, Nicole Washington, John D. Malone, Ashleigh Murphy Schafer, Nikos Gurfield, Sarah Stous, Rebecca Fielding‐Miller, Richard S. Garfein, Tommi Gaines, Cheryl A.M. Anderson, Natasha K. Martin and 18 more - Nature 2022 cited by 520

  6. TLR4 enhances TGF-β signaling and hepatic fibrosis

    Authors: , , , , , , - Nature Medicine 2007 cited by 1,910

  7. Mechanisms of liver fibrosis and its role in liver cancer

    Authors: , , , - Experimental Biology and Medicine 2020 cited by 441

  8. Aberrant iron distribution via hepatocyte-stellate cell axis drives liver lipogenesis and fibrosis

    Authors: , , , , , , , , , , , - Cell Metabolism 2022 cited by 210

  9. Magnetic Resonance Elastography vs Transient Elastography in Detection of Fibrosis and Noninvasive Measurement of Steatosis in Patients With Biopsy-Proven Nonalcoholic Fatty Liver Disease

    Authors: , , , , , , , , , , , , , , , - Gastroenterology 2016 cited by 697

  10. Interactions Between the Intestinal Microbiome and Liver Diseases

    Authors: , - Gastroenterology 2014 cited by 973

  11. Collagenolysis-dependent DDR1 signalling dictates pancreatic cancer outcome

    Authors: , , , , , , , , , , , , , , , , , , , , , , , - Nature 2022 cited by 241

  12. A Universal Gut-Microbiome-Derived Signature Predicts Cirrhosis

    Authors: , , , , , , , , , , , , , , , , , - Cell Metabolism 2020 cited by 336

  13. Myofibroblasts revert to an inactive phenotype during regression of liver fibrosis

    Authors: , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2012 cited by 788

  14. Enteric dysbiosis associated with a mouse model of alcoholic liver disease

    Authors: , , , , , , , , , - Hepatology 2010 cited by 780

  15. Intestinal FXR agonism promotes adipose tissue browning and reduces obesity and insulin resistance

    Authors: , , , , , , , , , , , , , , , , , , , , , - Nature Medicine 2015 cited by 711

  16. The Role of Fibrosis and Liver-Associated Fibroblasts in the Pathogenesis of Hepatocellular Carcinoma

    Authors: , , - International Journal of Molecular Sciences 2019 cited by 348

  17. Interleukin-17 Signaling in Inflammatory, Kupffer Cells, and Hepatic Stellate Cells Exacerbates Liver Fibrosis in Mice

    Authors: , , , , , , , , , , , , , , - Gastroenterology 2012 cited by 697

  18. Toll-Like Receptor 9 Promotes Steatohepatitis by Induction of Interleukin-1β in Mice

    Authors: , , , , , , , , - Gastroenterology 2010 cited by 731

  19. Resident fibroblast lineages mediate pressure overload–induced cardiac fibrosis

    Authors: , , , , , , , , , , , , , , , - Journal of Clinical Investigation 2014 cited by 621

  20. A gut microbiome signature for cirrhosis due to nonalcoholic fatty liver disease

    Authors: , , , , , , , , , , , , , , , - Nature Communications 2019 cited by 335

  21. Origin of myofibroblasts in the fibrotic liver in mice

    Authors: , , , , , , , , , , , , , , , , , - National Academy of Sciences, Proceedings of the National Academy of Sciences 2014 cited by 535

  22. IL-17 signaling in steatotic hepatocytes and macrophages promotes hepatocellular carcinoma in alcohol-related liver disease

    Authors: , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Hepatology 2019 cited by 210

  23. Magnetic resonance elastography predicts advanced fibrosis in patients with nonalcoholic fatty liver disease: A prospective study

    Authors: , , , , , , , , , , , - Hepatology 2014 cited by 477

  24. Modulation of the intestinal bile acid/farnesoid X receptor/fibroblast growth factor 15 axis improves alcoholic liver disease in mice

    Authors: , , , , , , , , , , , , , , , , , , , , - Hepatology 2017 cited by 275